Windlas Biotech

43
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0H5O01029
  • NSEID: WINDLAS
  • BSEID: 543329
INR
773.55
-17.4 (-2.2%)
BSENSE

Dec 05

BSE+NSE Vol: 10.03 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
759.00
630.00
513.00
465.00
427.00
328.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
759.00
630.00
513.00
465.00
427.00
328.00
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
9.00
-15.00
-4.00
3.00
-12.00
Raw Materials Consumed
493.00
386.00
340.00
307.00
270.00
224.00
Power & Fuel Cost
21.00
16.00
12.00
11.00
11.00
8.00
Employee Cost
122.00
87.00
70.00
63.00
58.00
43.00
Operating Expenses
11.00
10.00
8.00
8.00
8.00
4.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
12.00
15.00
10.00
6.00
4.00
6.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
4.00
6.00
5.00
3.00
5.00
3.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
665.00
552.00
452.00
413.00
372.00
287.00
Operating Profit (PBDIT) excl Other Income
94.00
78.00
60.00
52.00
54.00
41.00
Other Income
18.00
13.00
9.00
6.00
3.00
2.00
Operating Profit (PBDIT)
112.00
91.00
70.00
59.00
57.00
43.00
Interest
4.00
1.00
0.00
1.00
1.00
2.00
Profit before Depriciation and Tax
107.00
90.00
69.00
57.00
56.00
41.00
Depreciation
27.00
13.00
12.00
12.00
12.00
9.00
Profit Before Taxation & Exceptional Items
79.00
77.00
57.00
45.00
43.00
32.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
79.00
77.00
57.00
45.00
21.00
24.00
Provision for Tax
18.00
18.00
14.00
7.00
6.00
8.00
Profit After Tax
60.00
58.00
42.00
38.00
15.00
23.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
225.00
176.00
141.00
103.00
114.00
98.00
Profit Available for appropriations
286.00
234.00
184.00
141.00
129.00
114.00
Appropriations
286.00
234.00
184.00
141.00
129.00
114.00
Equity Dividend (%)
116.00%
110.00%
80.00%
70.00%
0.00%
0.00%
Earnings Per Share
29.19
27.97
19.70
18.58
8.70
8.90
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 20.43% vs 22.97% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 20.38% vs 29.80% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 296.56% vs 40.23% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 4.82% vs 36.51% in Mar 2024

Compare Profit and Loss Results of Windlas Biotech
Markets Mojo
Figures in Cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
759.00
0
759.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
759.00
0
759.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
-21.00
0
-21.00
0%
Raw Materials Consumed
493.00
0
493.00
0%
Power & Fuel Cost
21.00
0
21.00
0%
Employee Cost
122.00
0
122.00
0%
Operating Expenses
11.00
0
11.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
12.00
0
12.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
4.00
0
4.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
665.00
0
665.00
0%
Operating Profit (PBDIT) excl Other Income
94.00
0.00
94.00
0%
Other Income
18.00
0
18.00
0%
Operating Profit (PBDIT)
112.00
0
112.00
0%
Interest
4.00
0
4.00
0%
Profit before Depriciation and Tax
107.00
0
107.00
0%
Depreciation
27.00
0
27.00
0%
Profit Before Taxation & Exceptional Items
79.00
0
79.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
79.00
0
79.00
0%
Provision for Tax
18.00
0
18.00
0%
Profit After Tax
60.00
0
60.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
225.00
0
225.00
0%
Profit Available for appropriations
286.00
0
286.00
0%
Appropriations
286.00
0
286.00
0%
Equity Dividend (%)
116%
0%
116.00
Earnings Per Share
29.19
0
29.19
0%
Profit And Loss - Net Sales
Net Sales 759.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.43% vs 22.97% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 94.11 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.38% vs 29.80% in Mar 2024

Profit And Loss - Interest
Interest 4.38 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 296.56% vs 40.23% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 60.99 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.82% vs 36.51% in Mar 2024